2014-11-24

La Lumiere Closes $20 Million Series B Financing

Start-up skincare company La Lumiere, LLC, creator of the innovative illuMask®, the world's first wearable light therapy mask, announced today that it has secured a $20 million Series B financing.  The investment included Johnson & Johnson Development Corporation (JJDC), the venture capital subsidiary of Johnson & Johnson, joining SWaN & Legend Venture Partners as institutional investors in the company.  The Series B investment is a culmination of efforts over the last 12 months to drive commercialization in the U.S and continued growth.
Continue reading

Orchestrating displays for a business is no small feat. Displays are important as they play a key role in setting the tone and coordinating interaction in a physical space. However, each business have unique needs and it can get mind-boggling ... READ MORE

Ennostar Inc., a global leader in optoelectronic semiconductors, is partnering with X-Celeprint Ltd, the European pioneer in Micro-Transfer Printing (MTP) technology, to accelerate the adoption and commercialization of mass transfer technology... READ MORE